Market cap
$10.482 B
$50.87 +0.07%
Close of 6 Nov 2026
As of 6 Nov 2026, Qiagen (QGEN) has a market capitalization of $10.5B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$2.09B
#1108 by revenue
Earnings
$424.9M
#683 by earnings
Shares outstanding
216,920,735
Latest filing cover page
P/E ratio
24.7
Cap ÷ net income
Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap
All 163 →- #12Kymera TherapeuticsKYMR$10.8B
- #13RepligenRGEN$10.8B
- #14QiagenQGEN$10.5B
- #15VaxcytePCVX$9.84B
- #16Krystal BiotechKRYS$8.92B
What if Qiagen were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Qiagen are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.